← Back to headlines
Outlook Therapeutics Targets Ophthalmology Market with New Drug After FDA Rejection
Outlook Therapeutics is aiming for the multibillion-dollar ophthalmology market with a new drug, following a previous rejection by the FDA.
28 Jul, 21:31 — 28 Jul, 21:31
Sources
Showing 1 of 1 sources
